XeraCalm A.D
Effectiveness of lipid-replenishing balm on skin dryness induced by
anti-cancer treatments

Xeracalm AD
Status
Status :
Completed
Type of study
Post-marketing study
Min. Age
28
Years old
Max. Age
92
Years old
Gender
All

Brief summary

The objectives of this study were to evaluate the tolerance and effectiveness of XeraCalm A.D balm on the intensity of skin dryness in subjects undergoing anti-cancer treatment or in post-treatment.

The subjects' skin was evaluated during 2 medical consultations spaced one month apart.  

Area of application :
Oncology
Target :
Skin dryness
Dermo-cosmetic product :
XeraCalm A.D
Brand :
Eau Thermale Avène
Start Date :
07 September 2017
End Date :
26 July 2020
Number of subjects :

319

Countries :
Belgium
France
Spain
Study ID : RV4429A 2017 00